Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/60577
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVandyke, K.en
dc.contributor.authorDewar, A.en
dc.contributor.authorMenicanin, D.en
dc.contributor.authorTo, L.en
dc.contributor.authorHughes, T.en
dc.contributor.authorZannettino, A.en
dc.contributor.authorFitter, S.en
dc.date.issued2009en
dc.identifier.citationLeukemia, 2009; 23(11):2155-2159en
dc.identifier.issn0887-6924en
dc.identifier.issn1476-5551en
dc.identifier.urihttp://hdl.handle.net/2440/60577-
dc.description.statementofresponsibilityK. Vandyke, A.L. Dewar, S. Fitter, D. Menicanin, L.B. To, T.P. Hughes and A.C.W. Zannettinoen
dc.language.isoenen
dc.publisherNature Publishing Groupen
dc.rights© 2009 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.en
dc.subjectGrowth Plate; Animals; Humans; Rats; Rats, Sprague-Dawley; Growth Disorders; Piperazines; Pyrimidines; Antineoplastic Agents; Child; Female; Leukemia, Myelogenous, Chronic, BCR-ABL Positiveen
dc.titleImatinib mesylate causes growth plate closure in vivoen
dc.typeJournal articleen
dc.identifier.rmid0020091480en
dc.identifier.doi10.1038/leu.2009.150en
dc.identifier.pubid38300-
pubs.library.collectionMedical Sciences publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidVandyke, K. [0000-0002-1033-849X]en
dc.identifier.orcidMenicanin, D. [0000-0002-1178-2293]en
dc.identifier.orcidHughes, T. [0000-0002-0910-3730]en
dc.identifier.orcidZannettino, A. [0000-0002-6646-6167]en
dc.identifier.orcidFitter, S. [0000-0003-1663-6807]en
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.